Risk factor of non-tuberculous Mycobacterium infection in patients with rheumatoid arthritis and other autoimmune diseases receiving biologic agents: A multicenter …
H Ashizawa, T Takazono, S Kawashiri, N Nakada… - Respiratory …, 2024 - Elsevier
Background Evidence regarding the association of the usage of biologic agents (Etanercept,
Tocilizumab, adalimumab and so on), such as anti-tumor necrosis factor α, with the …
Tocilizumab, adalimumab and so on), such as anti-tumor necrosis factor α, with the …